Abiraterone Acetate Triggers ER Stress-Mediated Androgen Receptor Suppression via PERK/ATF4/CHOP Signaling in Prostate Cancer. Basaran E, Hacioglu C. Int J Urol 2025 Dec 3. doi: 10.1111/iju.70304.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Basaran E, Hacioglu C. Abiraterone Acetate Triggers ER Stress-Mediated Androgen Receptor Suppression via PERK/ATF4/CHOP Signaling in Prostate Cancer. Int J Urol 2025 Dec 3. doi: 10.1111/iju.70304.
PMID: 41339287